Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14356/2605| Title: | Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal |
| Authors: | Chapagain, Ram Hari |
| Issue Date: | 2024 |
| Publisher: | 24th FERCAP International Conference |
| Keywords: | Phase III clinical trial Children COVID- 19 pandemic Clinical research Nepal |
| Abstract: | Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal Dr. Ram Hari Chapagain Qualification: MD Pediatrics Chief Consultant Paediatrician: Kanti Children’s Hospital Associate Professor :NAMS Vice President : Nepal Paediatric Society Member : IRC , NAMS Research Involvemnt : Co Investigator : Typhoid Vaccine trial III Co Investigator : Zinc Sepsis Trial III PI : Cholera Vaccine Trial III Contact: chapagainrh2007@gmail.com |
| Description: | Presentation. |
| URI: | https://hdl.handle.net/20.500.14356/2605 |
| Appears in Collections: | DAY II: November 26, 2024; Parallel Sessions 4B: Vulnerability, Informed Consent and Assent Issues: Chairs: Phanthipha Wongwai & Jeevan Bahadur Sherchand, "Hall-B" 08:30-10:30 (Session 4) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 4B-2- Conducting a phase III clinical trial in children during the COVID19 pandemic Experience and lessons learnt from a clinical research facility of Nepal.pdf | Full Presentation.pdf | 912.84 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.